OBSOLETE: Dacryocystitis-osteopoikilosis syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1562
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Dacryocystitis-osteopoikilosis syndrome is an extremely rare condition that has been described in medical literature but is now considered an obsolete diagnostic term, meaning it is no longer recognized as a distinct syndrome by current medical classification systems. The condition was originally described as a combination of two features: dacryocystitis, which is inflammation or infection of the tear sac (the small pouch near the inner corner of the eye that collects tears before they drain into the nose), and osteopoikilosis, a usually harmless bone condition where small, round, dense spots appear on X-rays of various bones throughout the body. Dacryocystitis can cause tearing, redness, swelling, and pain near the inner corner of the eye, and sometimes discharge or recurrent infections. Osteopoikilosis is typically discovered incidentally on X-rays taken for other reasons and usually causes no symptoms on its own. Because this syndrome designation is now obsolete, it is likely that the two features were coincidentally present together or that the condition has been reclassified under a different or broader diagnosis. Patients who were previously given this diagnosis should discuss with their doctors whether their symptoms fit into a currently recognized condition. Treatment would generally focus on managing each component separately — antibiotics or surgery for dacryocystitis, and typically no treatment needed for osteopoikilosis.

Also known as:

Key symptoms:

Tearing or watery eyesSwelling near the inner corner of the eyeRedness around the tear sac areaEye pain or tenderness near the nose bridgeDischarge from the eye or tear ductRecurrent eye infectionsSmall dense bone spots seen on X-raysOccasional mild joint pain or stiffness

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Dacryocystitis-osteopoikilosis syndrome.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Dacryocystitis-osteopoikilosis syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Dacryocystitis-osteopoikilosis syndrome community →

No specialists are currently listed for OBSOLETE: Dacryocystitis-osteopoikilosis syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Dacryocystitis-osteopoikilosis syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Dacryocystitis-osteopoikilosis syndromeForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Dacryocystitis-osteopoikilosis syndrome.

Start the conversation →

Latest news about OBSOLETE: Dacryocystitis-osteopoikilosis syndrome

No recent news articles for OBSOLETE: Dacryocystitis-osteopoikilosis syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Is this diagnosis still considered valid, or should my condition be reclassified under a current diagnosis?,Are the dacryocystitis and bone findings related, or are they separate conditions?,Do I need surgery to fix my tear duct drainage, or can it be managed with medication?,Should my family members be screened for osteopoikilosis or related conditions?,Is genetic testing recommended to look for an underlying cause?,How often should I have follow-up eye exams?,Are there any activities or environmental factors I should avoid to prevent recurrent eye infections?

Common questions about OBSOLETE: Dacryocystitis-osteopoikilosis syndrome

What is OBSOLETE: Dacryocystitis-osteopoikilosis syndrome?

Dacryocystitis-osteopoikilosis syndrome is an extremely rare condition that has been described in medical literature but is now considered an obsolete diagnostic term, meaning it is no longer recognized as a distinct syndrome by current medical classification systems. The condition was originally described as a combination of two features: dacryocystitis, which is inflammation or infection of the tear sac (the small pouch near the inner corner of the eye that collects tears before they drain into the nose), and osteopoikilosis, a usually harmless bone condition where small, round, dense spots